Updated Jul 16, 2026
GOTTSCHALK ADRIAN is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Adrian Gottschalk is an executive in the biotechnology sector, currently associated with Foghorn Therapeutics Inc., a company focused on gene control and therapeutic development. He has held various leadership roles in the industry, contributing to advancements in therapeutic technologies.
| Role | Insider |
|---|---|
| Notability | 65/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-13 | FHTX | Foghorn Therapeutics Inc. | G — Bona-fide gift | 59.2K | $0.00 | |
| 2026-04-13 | FHTX | Foghorn Therapeutics Inc. | G — Bona-fide gift | 59.2K | $0.00 | |
| 2026-04-13 | FHTX | Foghorn Therapeutics Inc. | G — Bona-fide gift | 47.5K | $0.00 | |
| 2026-04-13 | FHTX | Foghorn Therapeutics Inc. | G — Bona-fide gift | 47.5K | $0.00 |
Adrian Gottschalk is an executive in the biotechnology sector, currently associated with Foghorn Therapeutics Inc., a company focused on gene control and therapeutic development. He has held various leadership roles in the industry, contributing to advancements in therapeutic technologies.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live GOTTSCHALK ADRIAN profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.